Real-life experience of tocilizumab use in COVID-19 patients

Rheumatology (Oxford). 2020 Aug 1;59(8):2163-2166. doi: 10.1093/rheumatology/keaa325.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab